Surveillance programmes for colorectal cancer in inflammatory bowel disease: Have we got it right?

Gut

Volumn 57, Issue 9, 2008, Pages 1194-1196

  Bernstein, Charles N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOENDOSCOPY; COLITIS; COLONOSCOPY; COLORECTAL CANCER; CROHN DISEASE; ENTERITIS; GASTROINTESTINAL BIOPSY; HEALTH PROGRAM; HEALTH SURVEY; NOTE; PRIORITY JOURNAL;

COLORECTAL NEOPLASMS; HUMANS; INFLAMMATORY BOWEL DISEASES; POPULATION SURVEILLANCE; PRECANCEROUS CONDITIONS;

EID: 50249093429     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2008.152009     Document Type: Note

References (30)

1. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994;343:71-4.
2. Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006;130:1030-8.
3. Ullman TA, Croog T, Harpaz N, et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 2003;125:1311-9.
4. Lim CH, Dixon MF, Vail A, et al. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut 2003;52:1127-32.
5. Odze R, Farraye FA, Hecht JL, et al. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2004;2:534-41.
6. Vieth M, Behrens H, Stolte M. Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment. Gut 2006;55:1151-5.
7. Bernstein CN, Weinstein WM, Levine DS, et al. Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol 1995;90:2106-14.
8. Eaden JA, Ward BA. Mayberry JF. How gastroenterologists screen for colonic cancer in ulcerative colitis: An analysis of performance. Gastrointest Endosc 2000;51:123-8.
9. Rubin CE, Haggftt RC, Burner GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;103:1611-20.
10. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003;124:880-8.
11. Rutter MD, Saunders BP, Schofield G, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004;53:256-60
12. Lutgeas MWMO, Vieggaar FP, Schipper MEI, et al. High frequency of early colorectal cancer in inflammatory bowel disease. Gut 2008;57:1246-51.
13. Bernstein CN. Low grade dysplasia in ulcerative colitis. Gastroenterology 2004;127:950-6.
14. Connell WR, Lennard-Jones JE, Williams CB, et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-44.
15. Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002;51(Suppl 5):V10-2.
16. Winawer S, Fletcher R, Rex D, et al. for the US Multisociety Task Force on Colorectal Cancer. Colorectal cancer screening and surveillance: Clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003;124:544-60.
17. Kzkowib SH, Present DH. for the Crohn's and Colitis Foundation of America Colon Cancer in IBD Study Group. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005;11:314-21.
18. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004;126:451-9.
19. Burgmann T, Clara I, Graff L, et al. The Manitoba IBD Cohort study: Prolonged symptoms before diagnosis -How much is IBS? Clin Gastroenterol Hepatol 2006;4:614-20.
20. Choi PM, Nugent FW, Schoetz DJ, et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993;105:418-24.
21. Karlen P, Kornfeld D, Brostrom O, et al. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 1998;42:711-4.
22. Eaden J, Abrams K, Ekbom A, et al. Colorectal cancer prevention in ulcerative colitis: a case control study. Aliment Pharmacol Ther 2000;14:145-53.
23. Velayos FS. Loftus EV Jr. Jess T, et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case control study. Gastroenterology 2006;130:1941-9.
24. Nuako KW, Ahlquist DA, Mahoney DW, et al. Familial predisposition for colorectal cancer in chronic ulcerative colitis: A case control study. Gastroenterology 1998;115:1079-83.
25. AsUmg J, Dickman PW, Karlen P, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 2001;120:1356-62.
26. Brentnal TA, Haggftt RC, Rabinovitch PS, et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996.110: 331-8.
27. Komfeld D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut 1997;41:522-5.
28. Shetty K, Rybicki L, Brzezinski A, et al. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1999;94:1643-9.
29. Eaden J, Abrams KR. Mayberry JF. The risk of CRC in ulcerative colitis: A meta-analysis. Gut 2001;48:526-35.
30. Rubio CA, Befrits R, Ljung t, et al. Colorectal carcinoma in ulcerative colitis is decreasing in Scandinavian countries. Anticancer Res 2001;21:2921-4.